author-photo

Adolfo Favaretto

18

Papers

1827

Citations

Citation Trend

Filter By

Papers (14) Sort By

Journal Conference Others

The role of immune microenvironment in small-cell lung cancer: Distribution of PD-L1 expression and prognostic role of FOXP3-positive tumour infiltrating lymphocytes

2018 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (43)
Negative prognostic factors and resulting clinical outcome in patients with metastatic renal cell carcinoma included in the Italian nivolumab-expanded access program

2018 Future Oncology
Show All
- Source
- Cite
- Save
Citations (6)
A clinical-genetic score to identify surgically resected colorectal cancer patients benefiting from an adjuvant fluoropyrimidine-based therapy

2018 Frontiers in Pharmacology
Show All
- Source
- Cite
- Save
Citations (5)
887PNegative prognostic factors and resulting clinical outcome in patients (pts) with metastatic renal cell carcinoma (mRCC) included in the Italian nivolumab expanded access program (EAP)

2017 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Oral vinorelbine plus cisplatin as first-line chemotherapy in nonsquamous non-small-cell lung cancer: final results of an International randomized phase II study (NAVotrial 01).

2014 Clinical Lung Cancer
Show All
- Source
- Cite
- Save
Citations (14)
Clinicopathological features of patients with malignant mesothelioma in a multicenter, retrospective study.

2014 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy

2013 Oncotarget
Show All
- Source
- Cite
- Save
Citations (19)
Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer

2012 Default journal
Show All
- Source
- Cite
- Save
Citations (0)
Erlotinib de primera línea seguido de quimioterapia con cisplatino‑gemcitabina de segunda línea en el cáncer de pulmón no microcítico avanzado: ensayo aleatorizado

2012
Show All
- Source
- Cite
- Save
Citations (0)
F1000Prime recommendation of Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301).

2012
- Adolfo Favaretto
Show All
- Source
- Cite
- Save
Citations (0)